Sundhedsvidenskabelig Forskning ved Aarhus - Institutleder til ...

MEDICINSK-KARDIOLOGISK AFDELING A, ÅRHUS UNIVERSITETSHOSPITAL,
ÅRHUS SYGEHUS
cardial infarction’, Danish Medical Bulletin, vol. 56,
nr. 3, s. 165-8.
Pedersen, OL, Christensen, KL, Bang, LE, Ibsen, H &
Schultz-Larsen, P 2009, ‘Farmakologisk hypertensionsbehandling’,
Ugeskrift for læger, vol. 171, nr.
24, s. 2022-5.
Schulman, S, Kearon, C, Kakkar, AK, Mismetti, P,
Schellong, S, Eriksson, H, Baanstra, D, Schnee, J,
Goldhaber, SZ & RE-COVER Study Group 2009, ‘Dabigatran
versus warfarin in the treatment of acute
venous thromboembolism’, New England Journal of
Medicine, vol. 361, nr. 24, s. 2342-52.
Storey, RF, Melissa Thornton, S, Lawrance, R, Husted,
S, Wickens, M, Emanuelsson, H, Cannon, CP,
Heptinstall, S & Armstrong, M 2009, ‘Ticagrelor
yields consistent dose-dependent inhibition of
ADP-induced platelet aggregation in patients with
atherosclerotic disease regardless of genotypic
variations in P2RY12, P2RY1, and ITGB3’, Platelets
(London), vol. 20, nr. 5, s. 341-8.
Strandberg, TE, Holme, I, Færgeman, O, Kastelein, JJP,
Lindahl, C, Larsen, ML, Olsson, AG, Pedersen, TR,
Tikkanen, MJ & IDEAL Study Group 2009, ‘Comparative
effect of atorvastatin (80 mg) versus simvastatin
(20 to 40 mg) in preventing hospitalizations
for heart failure in patients with previous myocardial
infarction’, American Journal of Cardiology,
vol. 103, nr. 10, s. 1381-5.
Tikkanen, MJ, Holme, I, Cater, NB, Szarek, M, Færgeman,
O, Kastelein, JJP, Olsson, AG, Larsen, ML,
Lindahl, C, Pedersen, TR & Incremental DEcrease
through Aggressive Lipid Lowering Investigators
2009, ‘Comparison of efficacy and safety of
atorvastatin (80 mg) to simvastatin (20 to 40 mg)
in patients aged or=65 years with
coronary heart disease (from the Incremental DEcrease
through Aggressive Lipid Lowering [IDEAL]
study)’, The American journal of surgery, vol. 103,
nr. 5, s. 577-82.
Tikkanen, MJ, Szarek, M, Fayyad, R, Holme, I, Cater,
NB, Kastelein, JJP, Olsson, AG, Færgeman, O, Larsen,
ML, Lindahl, C, Pedersen, TR & IDEAL Investigators
2009, ‘Total cardiovascular disease burden:
comparing intensive with moderate statin therapy
insights from the IDEAL (Incremental Decrease in
End Points Through Aggressive Lipid Lowering)
trial’, Journal of the American College of Cardiology,
vol. 54, nr. 25, s. 2353-7.
Wallentin, L, Becker, RC, Budaj, A, Cannon, CP, Emanuelsson,
H, Held, C, Horrow, J, Husted, S, James,
S, Katus, H, Mahaffey, KW, Scirica, BM, Skene, A,
Steg, PG, Storey, RF, Harrington, RA, PLATO Investigators,
Freij, A & Thorsén, M 2009, ‘Ticagrelor
versus clopidogrel in patients with acute coronary
syndromes’, New England Journal of Medicine, vol.
361, nr. 11, s. 1045-57.
APPRAISE Steering Committee and Investigators, Alexander,
JH, Becker, RC, Bhatt, DL, Cools, F, Crea, F,
Dellborg, M, Fox, KAA, Goodman, SG, Harrington,
RA, Huber, K, Husted, S, Lewis, BS, Lopez-Sendon,
J, Mohan, P, Montalescot, G, Ruda, M, Ruzyllo,
W, Verheugt, F & Wallentin, L 2009, ‘Apixaban,
an oral, direct, selective factor Xa inhibitor, in
combination with antiplatelet therapy after acute
coronary syndrome: results of the Apixaban for
Prevention of Acute Ischemic and Safety Events
(APPRAISE) trial’, Circulation (Baltimore), vol. 119,
nr. 22, s. 2877-85.
Kommentar/debat
Rasmussen, LH & Husted, S 2009, ‘Endoskopi af patienter
i antikoagulerende behandling I’, Ugeskrift for
læger, vol. 171, nr. 33, s. 2330.
Editorial
Thygesen, K, Katus, H, Giannitsis, E & Jaffe, A 2009,
‘Higher sensitivity troponin assays: Quo vadis?’,
European Heart Journal, vol. 30, s. 127-128.
Bidrag til videnskabelig rapport
Rasmussen, LH, Lassen, JF, Godtfredsen, J, Münster,
AB, Jespersen, J, Husted, S, Christensen, TD &
Pilegaard, H 2009, ‘Lungeemboli’, I, Den Nationale
kardiologiske Behandlingsvejledning - NBV2010.
Dansk Cardiologisk Selskab.
Rasmussen, LH, Lassen, JF, Godtfredsen, J, Münster,
AB, Jespersen, J, Husted, S, Christensen, TD &
Pilegaard, H 2009, ‘Peroral AK-behandling’, I, Den
Nationale kardiologiske Behandlingsvejledning -
NBV2010. Dansk Cardiologisk Selskab.
Rasmussen, LH, Jespersen, J, Münster, AB, Godtfredsen,
J, Husted, S, Lassen, JF, Christensen,
TD, Pilegaard, H, Sørensen, J & Olsen, J 2009,
‘Selvmonitoreret blodfortyndende behandling
- en kommenteret udenlandsk medicinsk teknologivurdering’,
I, Sundhedsstyrelsen, Monitorering
& Medicinsk Teknologivurdering. Kommenteret
Udenlandsk Medicinsk Teknologivurdering 2009;
2(1). Sundhedsstyrelsen.
172 Sundhedsvidenskabelig Forskning ved Aarhus Universitet og Århus Universitetshospital 2009